Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surfactant metabolism

A H Jobe1, M Ikegami

  • 1Department of Pediatrics, Harbor-UCLA Medical Center, Torrance.

Clinics in Perinatology
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Surfactant treatments are crucial for preterm infants with respiratory distress syndrome (RDS) as their lungs have small surfactant pools. Exogenous surfactant is efficiently recycled, not broken down, benefiting treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chorioamnionitis induces enteric nervous system injury: effects of timing and inflammation in the ovine fetus.

Molecular medicine (Cambridge, Mass.)·2020
Same author

Clinical interventions to reduce stillbirths in sub-Saharan Africa: a mathematical model to estimate the potential reduction of stillbirths associated with specific obstetric conditions.

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

The clinical use of corticosteroids in pregnancy.

Human reproduction update·2015
Same author

Antenatal exposure to chorioamnionitis affects lipid metabolism in 7-week-old sheep.

Journal of developmental origins of health and disease·2014
Same author

Antenatal ureaplasma infection impairs development of the fetal ovine gut in an IL-1-dependent manner.

Mucosal immunology·2012
Same author

What is BPD in 2012 and what will BPD become?

Early human development·2012

Area of Science:

  • Neonatal Physiology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Alveolar surfactant pool sizes are significantly reduced in preterm infants with respiratory distress syndrome (RDS).
  • Endogenous surfactant phospholipid synthesis and secretion are slow processes in the preterm lung.
  • Exogenous surfactant administration is the primary method for acutely augmenting surfactant levels.

Purpose of the Study:

  • To investigate the metabolic fate of exogenous surfactant in the preterm lung.
  • To understand the interaction between administered surfactant and endogenous surfactant components.
  • To elucidate the physiological basis for the efficacy of surfactant therapy in neonatal RDS.

Main Methods:

  • The study likely involved animal models of preterm birth and RDS.

Related Experiment Videos

  • Analysis of surfactant pool sizes, synthesis, secretion, and catabolism rates.
  • Investigation of the association of exogenous surfactant phospholipids and proteins with lung tissue and type II cells.

    • Main Results:

    • Surfactant phospholipids are poorly catabolized and rapidly recycled via lamellar bodies in preterm lungs.
    • Exogenous surfactant readily integrates with existing endogenous surfactant proteins.
    • Surfactant therapy does not impede the lung's natural surfactant synthesis and secretion pathways.

    Conclusions:

    • The preterm lung's capacity for efficient surfactant recycling and minimal catabolism contributes to the therapeutic benefits of surfactant treatment in RDS.
    • Exogenous surfactant effectively supplements and integrates with the endogenous system, supporting lung function.